 |
|
|
|
|
|
|
|
Pain Management and Beyond
At Teikoku, we discover new applications for transdermal drug delivery technologies and manufacture some of the most technically advanced products on the market quickly, effectively, and safely.
Lidoderm, launched in collaboration with Endo Pharmaceuticals in 1999, was Teikoku Pharma USA's first prescription U.S. product. The patch was designed to relieve the pain of post-herpetic neuralgia (a side effect of shingles) and was the first hydrogel patch approved by the FDA. In 2004, it was one of Endo Pharmaceutical's bestselling products.
Lidoderm is just one of many prescription and OTC products we manufacture and distribute to over 40 countries. In addition to an array of products for pain management, we are forging new ground in TDS-based health and beauty products, such as face masks, anti-wrinkle patches, skin whiteners, and cuticle softeners.
|
|
|
|
|
 |
Copyright © 2006 Teikoku Pharma USA, Inc. All Rights Reserved.
Teikoku Pharma USA, Teikoku, Teikoku Pharma, Teikoku Seiyaku Co., drug delivery systems, TDS, patches, unit-dose jellies, unit-dose liquids, creams and ointments, delivery products, pain management, cosmetic care, TDS technologies, patent protections, prescription, otcs, medical device market, applications, transdermal drug delivery technologies, Lidoderm, Endo Pharmaceuticals, post-herpetic neuralgia, TDS-based health and beauty products, face masks, anti-wrinkle patches, skin whiteners, and cuticle softe
|
|
Teikoku Brochure